Evaluation of Ceftazidime-avibactam and Ceftolozane-tazobactam Prescriptions in a Tertiary Hospital for Children in France: An Observational Study, 2017–2022
Our study suggests that CAZ/AVI and C/T are reasonable treatment options for children infected with Gram-negative pathogens resistant to carbapenems.
Authors
- Julie Toubiana (ORCID: https://orcid.org/0000-0001-9561-669X)
- Robert Ratiney
- M. Husain (ORCID: https://orcid.org/0000-0001-7704-9628)
- Jérémie F. Cohen (ORCID: https://orcid.org/0000-0003-3572-8985)
- Perrine Parize (ORCID: https://orcid.org/0000-0002-0786-7518)
- Marion Grimaud
- Hervé Lécuyer (ORCID: https://orcid.org/0000-0002-9227-4070)
- Charlotte Roy (ORCID: https://orcid.org/0000-0001-8274-7180)
- Pauline Labé
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Institut Pasteur (FR)
- Université Paris Cité (FR)
- Institut Necker Enfants Malades (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1097/inf.0000000000004768
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59